ConductScience.org, home

Paper36924120

The clinical management of hepatocellular carcinoma in China: Progress and challenges.

Shan S and 1 other. Clin Mol Hepatol, 2023. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. The clinical management of hepatocellular carcinoma in China: Progress and challenges. Papers, record 36924120. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36924120

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The clinical management of hepatocellular carcinoma in China: Progress and challenges.
PubMed
Journal
Clin Mol Hepatol
PubMed
Year
2023
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
2
iCite
Revised in PubMed
2023-04-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shan SShan
2Jia JJidong

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Humans
East Asian People
China

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82000569National Natural Science Foundation of ChinaPubMed
82270603National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on36545708Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective.https://conductscience.org/library/papers/36545708

Source PubMed

Download CSV of comments and corrections

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132963466A study protocol of population-based cancer screening cohort study on esophageal, stomach and liver cancer in rural China.Chin J Cancer Res2020https://conductscience.org/library/papers/32963466PubMed
230404026Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.Gastroenterology2019https://conductscience.org/library/papers/30404026PubMed
334846705Consensus on the secondary prevention of primary liver cancer.Hepatol Int2021https://conductscience.org/library/papers/34846705PubMed
434805067Disparities in Hepatocellular Carcinoma Survival by Insurance Status: A Population-Based Study in China.Front Public Health2021https://conductscience.org/library/papers/34805067PubMed
530143694Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China.Sci Rep2018https://conductscience.org/library/papers/30143694PubMed
631385465Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.Cancer Med2019https://conductscience.org/library/papers/31385465PubMed
735800051Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.Front Oncol2022https://conductscience.org/library/papers/35800051PubMed
834823308The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection.Clin Mol Hepatol2022https://conductscience.org/library/papers/34823308PubMed
936304493Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022).J Clin Transl Hepatol2022https://conductscience.org/library/papers/36304493PubMed
1015042359Randomized controlled trial of screening for hepatocellular carcinoma.J Cancer Res Clin Oncol2004https://conductscience.org/library/papers/15042359PubMed
119222303Prospective study of early detection for primary liver cancer.J Cancer Res Clin Oncol1997https://conductscience.org/library/papers/9222303PubMed
1236545708Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective.Clin Mol Hepatol2023https://conductscience.org/library/papers/36545708PubMed
1333317248Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects.Clin Mol Hepatol2021https://conductscience.org/library/papers/33317248PubMed
1436207940[The consensus on tertiary prevention of primary liver cancer (2022 version)].Zhonghua Gan Zang Bing Za Zhi2022https://conductscience.org/library/papers/36207940PubMed
1536263667Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.Clin Mol Hepatol2022https://conductscience.org/library/papers/36263667PubMed
1636764320Global reporting of progress towards elimination of hepatitis B and hepatitis C.Lancet Gastroenterol Hepatol2023https://conductscience.org/library/papers/36764320PubMed
1734590058Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China.Lancet Reg Health West Pac2021https://conductscience.org/library/papers/34590058PubMed
1830605974[Strategies of primary prevention of liver cancer in China: expert consensus (2018)].Zhonghua Yu Fang Yi Xue Za Zhi2019https://conductscience.org/library/papers/30605974PubMed
1931283409Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.J Clin Oncol2019https://conductscience.org/library/papers/31283409PubMed
2025549238Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.PLoS Med2014https://conductscience.org/library/papers/25549238PubMed

See all 23 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42953582Psychological Stress in Hepatocellular Carcinoma: Clinical Outcomes and Biological Mechanisms.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42953582PubMed
42757287Bibliometric Analysis of Gut Microbiota and Hepatocellular Carcinoma: Research Trends and Frontiers.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42757287PubMed
42703451Application value of dual-phase cone-beam computed tomography during hepatic arteriography in the detection of ≤2 cm hypervascular hepatocellular carcinoma and its feeding arteries.J Gastrointest Oncol2026https://conductscience.org/library/papers/42703451PubMed
42703324
Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.
J Gastrointest Oncol2026https://conductscience.org/library/papers/42703324PubMed
42384246CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway.Hum Cell2026https://conductscience.org/library/papers/42384246PubMed
42181737ENPP2 Dysregulation Defines a Candidate Biomarker Axis Coupling Tumor-Intrinsic cAMP Signaling to Macrophage Polarization in Hepatocellular Carcinoma.Hum Mutat2026https://conductscience.org/library/papers/42181737PubMed
41403946LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort.Front Immunol2025https://conductscience.org/library/papers/41403946PubMed
41368427
Effect of External Oblique Intercostal Block on Postoperative Analgesia and Early Recovery in Patients Undergoing Open Liver Resection for Hepatocellular Carcinoma or Intrahepatic Bile Duct Stones: A Randomized Controlled Clinical Trial.
Local Reg Anesth2025https://conductscience.org/library/papers/41368427PubMed
41237121MRI-based 2.5D deep learning and radiomics effectively predicted microvascular invasion and Ki-67 expression in hepatocellular carcinoma.PLoS One2025https://conductscience.org/library/papers/41237121PubMed
41026296Long noncoding RNA RHPN1-AS1 promotes hepatocellular carcinoma progression under hypoxia through interaction with RPS15A protein.Med Oncol2025https://conductscience.org/library/papers/41026296PubMed
40823339Refining Prognosis and Treatment Strategies Beyond the Barcelona Clinic Liver Cancer Stage in Hepatocellular Carcinoma with Lung Metastases: A Multicenter Cohort Study.MedComm (2020)2025https://conductscience.org/library/papers/40823339PubMed
40682115SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40682115PubMed
40636084Tumor burden score and alpha-fetoprotein level predict prognosis of patients with unresectable hepatocellular carcinoma treated with tyrosine kinase inhibitor and anti-PD-1 antibody.ILIVER2024https://conductscience.org/library/papers/40636084PubMed
40283886Preparation and Evaluation of Hepatoma-Targeting Glycyrrhetinic Acid Composite Micelles Loaded with Curcumin.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40283886PubMed
39663164Camrelizumab plus rivoceranib compared sorafenib as first-line therapeutic options for advanced hepatocellular carcinoma in China: a cost-effectiveness analysis.BMJ Open2024https://conductscience.org/library/papers/39663164PubMed
38997297Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma.Cell Death Dis2024https://conductscience.org/library/papers/38997297PubMed
38814517β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression.Hum Cell2024https://conductscience.org/library/papers/38814517PubMed
38399792How Possible Is the Elimination of Viral Hepatitis? An Analysis Based on the Global Burden of Disease from Hepatitis B and C, 1990-2019.Microorganisms2024https://conductscience.org/library/papers/38399792PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36924120

GET https://conductscience.org/api/papers/v1/36924120/references?page=2